MASH Treatment Reinvented: The Role of Cutting-Edge Pharmaceuticals
MASH Treatment Reinvented: The Role of Cutting-Edge Pharmaceuticals The Turning Point: How REZDIFFRA’s Approval is Redefining MASH Treatment The approval of Rezdiffra represents a groundbreaking development in the treatment of metabolic-associated steatohepatitis (MASH), significantly altering the therapeutic approach for this liver disease